Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Fuad El-Rassi"'
Autor:
Lakshmanan Krishnamurti, Staci D Arnold, Ann Haight, Allistair Abraham, Gregory MT Guilcher, Tami John, Nitya Bakshi, Shalini Shenoy, Karen Syrjala, Paul L Martin, Sonali Chaudhury, Gretchen Eames, Olusola Festus Olowoselu, Matthew Hsieh, Josu De La Fuente, Kimberly A Kasow, Elizabeth Stenger, Anne Mertens, Fuad El-Rassi, Peter Lane, Bronwen E Shaw, Lillian Meacham, David Archer
Publikováno v:
JMIR Research Protocols, Vol 11, Iss 7, p e36780 (2022)
BackgroundThere are sparse data on the long-term and late effects of hematopoietic cell transplantation (HCT) for sickle cell disease (SCD). ObjectiveThis study aims to establish an international registry of long-term outcomes post-HCT for SCD and d
Externí odkaz:
https://doaj.org/article/30e5d87919a54832b17b351f26b0d417
Autor:
Carlton D. Dampier, Marilyn Jo Telen, Ted Wun, R. Clark Brown, Payal Desai, Fuad El Rassi, Beng Fuh, Julie Kanter, Yves Pastore, Jennifer Rothman, James G. Taylor, David Readett, Krupa M. Sivamurthy, Brinda Tammara, Li-Jung Tseng, Jay Nelson Lozier, Helen Thackray, John L. Magnani, Kathryn L. Hassell
Publikováno v:
Blood. 141:168-179
The efficacy and safety of rivipansel, a predominantly E-selectin antagonist, were studied in a phase 3, randomized, controlled trial for vaso-occlusive crisis (VOC) requiring hospitalization (RESET). A total of 345 subjects (204 adults and 141 child
Autor:
Karen Clarke, Yoo Mee Shin, Mary Ann Kirkconnell Hall, Mohamad Moussa, Morgan McLemore, Fuad El Rassi
Publikováno v:
Expert Review of Hematology. 16:151-156
Compared with the general population, patients with sickle cell disease (SCD) typically have substantially reduced life expectancies. It is unclear whether SCD patients who acquire COVID-19 have higher rates of complications and mortality than the ge
Autor:
Ifeyinwa Osunkwo, John James, Fuad El‐Rassi, Alecia Nero, Caterina P. Minniti, Cassandra Trimnell, Jincy Paulose, Nicholas Ramscar, Tom Bailey, Olivera Rajkovic‐Hooley, Biree Andemariam
Publikováno v:
American Journal of Hematology. 97:1055-1064
The international Sickle Cell World Assessment Survey (SWAY) reported a high impact of sickle cell disease (SCD) on patients' daily lives globally. In this study, we analyzed whether the reported burden differed between patients from the USA (n = 384
Autor:
Alan Anderson, Fuad El Rassi, Michael R. DeBaun, Modupe Idowu, Julie Kanter, Soheir Adam, Susanna Curtis, Darla Liles, Biree Andemariam, Morgan L. McLemore, Robert Sheppard Nickel, Poornima Ramadas, Jincy Paulose, Dramane I Laine, Mahmudul Khan, Deepika S. Darbari, Arthur L. Burnett
Publikováno v:
Blood. 140:1636-1638
Autor:
Karen Clarke, Karima Benameur, Zanthia Wiley, Yoo Mee Shin, Mohamad Moussa, Fuad El Rassi, Morgan McLemore
Publikováno v:
Journal of investigative medicine high impact case reports. 10
Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection is commonly associated with neurological complications. Patients with sickle cell disease are at increased risk of developing neurologic complications throughout their lifetimes and
Publikováno v:
Blood. 140:8308-8309
Autor:
Fuad El Rassi, Martha Arellano
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2013, Iss 7, Pp 181-197 (2013)
Externí odkaz:
https://doaj.org/article/f83f4fd1c44342b99948bb670ab55a2a
Publikováno v:
Advances in chronic kidney disease. 29(2)
Sickle cell disease causes several kidney manifestations. They include defects in urine concentration, impaired handling of potassium and hydrogen ion, albuminuria, acute kidney injury, and chronic kidney disease to name a few. Glomerular hyperfiltra
Autor:
Raffaella Colombatti, Alecia C. Nero, Erfan Nur, Cassandra Trimnell, John R. James, Olivera Rajkovic-Hooley, Tom Bailey, Jean-Benoît Arlet, Mariane de Montalembert, Ifeyinwa Osunkwo, Caterina P. Minniti, Suman Jain, Miguel R. Abboud, Fuad El Rassi, Beverley Francis-Gibson, Wasil Jastaniah, Biree Andemariam, Nicholas Ramscar, Marimilia Pita, Baba Inusa
Publikováno v:
Blood. 136:8-10
Background: SWAY was a cross-sectional survey that assessed the global impact and treatment of sickle cell disease (SCD) (James et al. ASH 2019). SCD puts patients at risk of multiple complications driven by vaso-occlusion and hemolytic anemia. Vaso-